18 December 2020

Armand Bensussan awarded the Galien Prize 2020

Professor Martine Bagot and Professor Armand Bensussan are rewarded for their research on the development of a targeted therapy, lacutamab, a monoclonal antibody targeting the tumor antigen KIR3DL2 for the treatment of patients with advanced, refractory and relapsed T cell lymphomas, particularly erythrodermic cutaneous T cell lymphomas. The Galien Prize here rewards two decades of research.
Season’s greetings
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more